Log in to save to my catalogue

Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patie...

Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patie...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_034a51b74e4c41b99fb3a6231b9dd832

Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren’s Syndrome

About this item

Full title

Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren’s Syndrome

Publisher

Basel: MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2023-09, Vol.13 (9), p.1384

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates lipid metabolism contributing to cardiovascular (CV) risk in the general population. The relationship between PCSK9 and CV risk in systemic autoimmune diseases has been poorly explored. We investigated the association between plasma PCSK9, measures of immune–inflammatory status and mar...

Alternative Titles

Full title

Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren’s Syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_034a51b74e4c41b99fb3a6231b9dd832

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_034a51b74e4c41b99fb3a6231b9dd832

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom13091384

How to access this item